Latest news and press releases about Inotiv, Inc. (NOTV): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS).
Price
| Price | $0.08 |
| Market Cap | $3M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.04 |
| EV / EBITDA | 46.61 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -74.67% |
| Return on Invested Capital | -6.25% |
| Return on Assets | -12.38% |
| Gross Margin | 14.70% |
| Operating Margin | -8.87% |
| Net Margin | -17.14% |
Related companies: BDSX · BEAT · BIAF · CELU · FGEN · KZR · QNTM
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of NOTV: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks